Katherine Callaway Kim

Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease

Jing Luo, Robert Feldman, Katherine Callaway Kim et al. · JAMA Network Open · 2023 · 66 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Drug Shortages Prior to and During the COVID-19 Pandemic

Katherine Callaway Kim, Scott D. Rothenberger, Mina Tadrous et al. · JAMA Network Open · 2024 · 49 citations · Full text

Pharmacy, Pharmacy Practice, Supply Chain Management +13

Concurrent hiatal hernia repair and bariatric surgery: outcomes after sleeve gastrectomy and Roux-en-Y gastric bypass

Kristina H. Lewis, Katherine Callaway Kim, Stephanie Argetsinger et al. · Surgery for Obesity and Related Diseases · 2020 · 43 citations · Full text

Medicine, Surgery, Gastroenterology +12

Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database

Kristina H. Lewis, David Arterburn, Katherine Callaway Kim et al. · JAMA Network Open · 2019 · 39 citations · Full text

Medicine, Perioperative Medicine, Surgery +12

The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis

Katie J. Suda, Katherine Callaway Kim, Inmaculada Hernandez et al. · Journal of the American Pharmacists Association · 2021 · 36 citations · Full text

Public Health, Health Sciences, Epidemiology +5